Comparison of the efficacy of a generic plerixafor versus Mozobil as adjunct peripheral blood stem cell mobilization agents in multiple myeloma patients
The generic plerixafor produced comparable cumulative collection yields and early engraftment outcomes as Mozobil, but fewer doses and collection days were needed to reach collection goal.
Authors
- Hoim Kim
- Shelley Chang
- Shan Yuan (ORCID: https://orcid.org/0000-0002-9424-1790)
- Shirong Wang (ORCID: https://orcid.org/0000-0002-1860-2523)
Institutions
- University of Southern California (US)
- City Of Hope National Medical Center (US)
Publication Details
- Journal
- Transfusion
- Published
- 2024-10-04
- DOI
- https://doi.org/10.1111/trf.18033
- Citations
- 1
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Hope Center for Neurological Disorders